Former President Benigno Aquino III has a case against him filed at the Office of the Ombudsman together with some of his cabinet members.
Some parents with children vaccinated with Dengvaxia filed a case against former president and to former Health Secretary Janette Garin, former Budget Secretary Florencio Abad and former Executive Secretary Paquito Ochoa and some Sanofi officials.
It was determined in the complaint that these officials knew the negative result of the deal they had entered with the French pharmaceutical company.
They cannot let cases like this just came to pass where officials neglected the review and assessment of the new vaccine.
Fast tracked Deal
In April 4, 2016, former President Noynoy Aquino personally witnessed when then Department of Health Secretary Janette Garin administered the first dose of Dengvaxia to a nine-year old grade school pupil.
In his speech, he emphasized the former government’s efforts in improving the health services in the country.
Through this Dengue Vaccine School-based Immunization, it amplified the provision of free dengue vaccine to indigent public school students in three regions in the country with the highest dengue incidence, including the National Capital Region (NCR), Regions III (Central Luzon), and IV-A (Calabarzon).
The Pnoy administration purchased a P3.5 Billion worth of Sanofi Pasteur’s Dengvaxia even if WHO warned some risks before issuing its safety guidelines.
Fast-track 2017, the World Health Organization document stated that Dengvaxia was later found out to be dangerous, but only after it was been used already for more than 700, 000 children in the Philippines.
WHO said that children 9 years old and above who are vaccinated when seronegative could be at an increased risk.
Last week, former TESDA Director General and Iloilo Rep. Augusto Syjuco, Jr. charged Aquino and former Department of Health Secretary Janet Garin for mass murder and plunder over the Dengvaxia scam.
Department of Health has already suspended the massive vaccination program, while the Food and Drug Administration (FDA) has ordered Sanofi to stop the sale, distribution, and marketing of Dengvaxia.